List of Excipients in API carbidopa and levodopa
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbidopa and levodopa
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | ALUMINUM OXIDE | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | CELLULOSE, MICROCRYSTALLINE | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | CROSPOVIDONE | |
| Merck Sharp & Dohme Corp | SINEMET | carbidopa and levodopa | 0006-3915 | FD&C BLUE NO. 2 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing carbidopa and levodopa
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 | CELLULOSE, MICROCRYSTALLINE |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 | FD&C BLUE NO. 2--ALUMINUM LAKE |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 | MAGNESIUM STEARATE |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 | STARCH, CORN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for carbidopa and levodopa
Excipient focus: ALCOHOL
carbidopa and levodopa drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
carbidopa and levodopa drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-8010 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
carbidopa and levodopa drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARTAME
carbidopa and levodopa drug variants containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
carbidopa and levodopa drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM SILICATE
carbidopa and levodopa drug variants containing CALCIUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CALCIUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
carbidopa and levodopa drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
carbidopa and levodopa drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
carbidopa and levodopa drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0088 |
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-4569 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
carbidopa and levodopa drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
carbidopa and levodopa drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
carbidopa and levodopa drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| Aphena Pharma Solutions - Tennessee LLC | carbidopa and levodopa | 43353-202 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0088 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
carbidopa and levodopa drug variants containing D&C YELLOW NO. 10
carbidopa and levodopa drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
carbidopa and levodopa drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbidopa and levodopa | 0904-7257 |
| Major Pharmaceuticals | carbidopa and levodopa | 0904-7501 |
| AvKARE | carbidopa and levodopa | 42291-472 |
| A-S Medication Solutions | carbidopa and levodopa | 50090-3419 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
carbidopa and levodopa drug variants containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
carbidopa and levodopa drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
carbidopa and levodopa drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
carbidopa and levodopa drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0088 |
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-4569 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
carbidopa and levodopa drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | carbidopa and levodopa | 42291-488 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
carbidopa and levodopa drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| AvKARE | carbidopa and levodopa | 42291-471 |
| Mayne Pharma Inc | carbidopa and levodopa | 51862-078 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0088 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
carbidopa and levodopa drug variants containing FD&C RED NO. 40
carbidopa and levodopa drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
carbidopa and levodopa drug variants containing FD&C YELLOW NO. 6
carbidopa and levodopa drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE
carbidopa and levodopa drug variants containing FD&C YELLOW NO. 6 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | carbidopa and levodopa | 0904-7501 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FD&C YELLOW NO. 6 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
carbidopa and levodopa drug variants containing FERRIC OXIDE RED
carbidopa and levodopa drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
carbidopa and levodopa drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | carbidopa and levodopa | 16729-079 |
| BluePoint Laboratories | carbidopa and levodopa | 68001-172 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
carbidopa and levodopa drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
carbidopa and levodopa drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
carbidopa and levodopa drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0088 |
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-4569 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
carbidopa and levodopa drug variants containing HYPROMELLOSE
carbidopa and levodopa drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
carbidopa and levodopa drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0088 |
| Accord Healthcare Inc | carbidopa and levodopa | 16729-079 |
| Mylan Institutional Inc | carbidopa and levodopa | 51079-978 |
| Physicians Total Care Inc | carbidopa and levodopa | 54868-5659 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
carbidopa and levodopa drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | carbidopa and levodopa | 16729-079 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| BluePoint Laboratories | carbidopa and levodopa | 68001-172 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
carbidopa and levodopa drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-4569 |
| NCS HealthCare of KY LLC dba Vangard Labs | carbidopa and levodopa | 0615-8180 |
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 62756-461 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
carbidopa and levodopa drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
carbidopa and levodopa drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
carbidopa and levodopa drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | carbidopa and levodopa | 16729-079 |
| BluePoint Laboratories | carbidopa and levodopa | 68001-172 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM PALMITOSTEARATE
carbidopa and levodopa drug variants containing MAGNESIUM PALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply | carbidopa and levodopa | 60429-650 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MAGNESIUM PALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
carbidopa and levodopa drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| Golden State Medical Supply | carbidopa and levodopa | 60429-650 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
carbidopa and levodopa drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
carbidopa and levodopa drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
carbidopa and levodopa drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | carbidopa and levodopa | 70710-1721 |
| Zydus Lifesciences Limited | carbidopa and levodopa | 70771-1694 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
carbidopa and levodopa drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| Golden State Medical Supply | carbidopa and levodopa | 60429-650 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
carbidopa and levodopa drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
carbidopa and levodopa drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
carbidopa and levodopa drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
carbidopa and levodopa drug variants containing SILICON DIOXIDE
carbidopa and levodopa drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
carbidopa and levodopa drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
carbidopa and levodopa drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
carbidopa and levodopa drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | carbidopa and levodopa | 50090-3857 |
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 62756-517 |
| Bryant Ranch Prepack | carbidopa and levodopa | 63629-2355 |
| Bryant Ranch Prepack | carbidopa and levodopa | 63629-2356 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
carbidopa and levodopa drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
carbidopa and levodopa drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
carbidopa and levodopa drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0088 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-5051 |
| NCS HealthCare of KY Inc dba Vangard Labs | carbidopa and levodopa | 0615-4569 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
carbidopa and levodopa drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | carbidopa and levodopa | 47335-186 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
carbidopa and levodopa drug variants containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing TARTARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
carbidopa and levodopa drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
carbidopa and levodopa drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-661 |
| Amneal Pharmaceuticals LLC | carbidopa and levodopa | 64896-967 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
carbidopa and levodopa drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | carbidopa and levodopa | 0074-3012 |
| >Company | >Ingredient | >NDC |
carbidopa and levodopa drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | carbidopa and levodopa | 0006-3915 |
| Teva Pharmaceuticals USA Inc | carbidopa and levodopa | 0093-9701 |
| Actavis Pharma Inc | carbidopa and levodopa | 0228-2538 |
| Mylan Pharmaceuticals Inc | carbidopa and levodopa | 0378-0078 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
